Advertisement

PharmacoEconomics

, Volume 37, Issue 2, pp 291–291 | Cite as

Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand

  • Bunchai Chongmelaxme
  • Pochamana Phisalprapa
  • Ratree Manthaisong
  • Piyameth DilokthornsakulEmail author
  • Nathorn ChaiyakunaprukEmail author
Correction

1 Correction to: PharmacoEconomics  https://doi.org/10.1007/s40273-018-0736-0

The title of the article should read:

Weight Reduction is Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand.

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.Center of Pharmaceutical Outcomes Research, Department of Pharmacy Practice, Faculty of Pharmaceutical SciencesNaresuan UniversityPhitsanulokThailand
  2. 2.Department of Medicine, Faculty of Medicine Siriraj HospitalMahidol UniversityBangkokThailand
  3. 3.Clinical Pharmacy Research Unit, Department of Clinical Pharmacy, Faculty of PharmacyMahasarakham UniversityMahasarakhamThailand
  4. 4.School of PharmacyMonash University MalaysiaSelangorMalaysia
  5. 5.School of PharmacyUniversity of WisconsinWisconsinUSA
  6. 6.Asian Centre for Evidence Synthesis in Population, Implementation and Clinical Outcomes (PICO), Health and Well-Being Cluster, Global Asia in the 21st Century (GA21) PlatformMonash University MalaysiaBandar SunwayMalaysia

Personalised recommendations